-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Ibere Pharmaceuticals quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate for 2021.
- Ibere Pharmaceuticals Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was $790K, a 54.4% decline year-over-year.
- Ibere Pharmaceuticals Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was $6.19M, a 412% increase year-over-year.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)